WallStreetZenWallStreetZen

NASDAQ: NEUP
Neuphoria Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Neuphoria Therapeutics revenue was $10.41M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, NEUP annual revenue was $10.3M, with Infinity% growth year-over-year.

NEUP past revenue growth

How has NEUP's revenue growth performed historically?

Company
2,343.54%
Industry
379.98%
Market
88.6%
NEUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NEUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NEUP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NEUP revenue history

Current Revenue
$10.1M
Current Earnings
-$3.8M
Current Profit Margin
-37.8%

Be the first to know when NEUP announces revenue.

NEUP Revenue History By Year

NEUP Yearly RevenueNEUP RevenueNEUP ChangeNEUP Revenue Growth
2025-06-30$10.30MN/AN/A
2024-06-30$0.00N/AN/A
2023-06-30$0.00-$183.08k-100.00%
2022-06-30$183.08kN/AN/A
2021-06-30$0.00-$32.18k-100.00%
2020-06-30$32.18kN/AN/A

1 of 1

Neuphoria Therapeutics Revenue FAQ

What was NEUP's revenue last quarter?

Neuphoria Therapeutics (NASDAQ: NEUP) reported Q4 2025 revenue of $0.00 up 100% year over year. In the same quarter last year, Neuphoria Therapeutics's revenue was $411.62 thousand.

What was Neuphoria Therapeutics's revenue in 2025?

Neuphoria Therapeutics's annual revenue for the twelve months ending Jun 30, 2025 was $10.30 million, a Infinity% increase year over year.

How much does Neuphoria Therapeutics make in a day?

Based on Neuphoria Therapeutics annual revenue for the past five years, NEUP makes an average of $5,741.79 per day.

What was Neuphoria Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Neuphoria Therapeutics's revenue has grown 2,343.54% year over year. This is 1,963.57 percentage points higher than the US Biotechnology industry revenue growth rate of 379.98%. Neuphoria Therapeutics's revenue in the past year totaled $10.41 million.

How much does Neuphoria Therapeutics make in a year?

Neuphoria Therapeutics's revenue by year for the past five years is:
  • Neuphoria Therapeutics's revenue for the twelve months ending Jun 30, 2025 was $10.30 million, a Infinity% increase year over year.
  • Neuphoria Therapeutics's annual revenue for Jun 30, 2024 was $0.00, a N/A decrease from 2023.
  • Neuphoria Therapeutics's annual revenue for 2023 was $0.00, a 100% decrease from 2022.
  • Neuphoria Therapeutics's annual revenue for 2022 was $183.08 thousand, a Infinity% increase from 2021.
  • Neuphoria Therapeutics's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.